Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma

doi:10.4254/wjh.v13.i11.1753

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4336)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

259

WORD

105

HTML

2010

Figures (1-3)

231

Tables (1-4)

278

Sum=2883

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

439

Download

1014

Sum=1453

Nov 27, 2021 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Hepatol. Nov 27, 2021; 13(11): 1753-1765
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1753

Table 4 Univariate and multivariate regression analyses for the parameters affecting metastasis in hepatocellular carcinoma group

	Univariate		Multivariate
	P value	OR (95%CI)	P value	OR (95%CI)
microRNA 9-3p	0.008	0.193 (0.057-0.653)	0.041	0.291 (0.089-0.951)
Endocan	0.023	1.002 (1.000-1.003)	0.358	1.001 (0.999-1.002)

Statistically significant at P ≤ 0.05. OR: Odds ratio; CI: Confidence interval.

Citation: Wahb AMSE, El Kassas M, Khamis AK, Elhelbawy M, Elhelbawy N, Habieb MSE. Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma. World J Hepatol 2021; 13(11): 1753-1765
URL: https://www.wjgnet.com/1948-5182/full/v13/i11/1753.htm
DOI: https://dx.doi.org/10.4254/wjh.v13.i11.1753